Literature DB >> 21946268

Microglial signalling mechanisms: Cathepsin S and Fractalkine.

Anna K Clark1, Marzia Malcangio.   

Abstract

A recent major conceptual advance has been the recognition of the importance of immune system-neuron interactions in the modulation of spinal pain processing. In particular, pro-inflammatory mediators secreted by immune competent cells such as microglia modulate nociceptive function in the injured CNS and following peripheral nerve damage. Chemokines play a pivotal role in mediating neuronal-microglial communication which leads to increased nociception. Here we examine the evidence that one such microglial mediator, the lysosomal cysteine protease Cathepsin S (CatS), is critical for the maintenance of neuropathic pain via cleavage of the transmembrane chemokine Fractalkine (FKN). Both CatS and FKN mediate critical physiological functions necessary for immune regulation. As key mediators of homeostatic functions it is not surprising that imbalance in these immune processes has been implicated in autoimmune disorders including Multiple Sclerosis and Rheumatoid Arthritis, both of which are associated with chronic pain. Thus, impairment of the CatS/FKN signalling pair constitutes a novel therapeutic approach for the treatment of chronic pain. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21946268     DOI: 10.1016/j.expneurol.2011.09.012

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  51 in total

Review 1.  Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain.

Authors:  Gang Chen; Yu-Qiu Zhang; Yawar J Qadri; Charles N Serhan; Ru-Rong Ji
Journal:  Neuron       Date:  2018-12-19       Impact factor: 17.173

Review 2.  Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes.

Authors:  Reik Löser; Jens Pietzsch
Journal:  Front Chem       Date:  2015-06-23       Impact factor: 5.221

3.  Selective activation of microglia facilitates synaptic strength.

Authors:  Anna K Clark; Doris Gruber-Schoffnegger; Ruth Drdla-Schutting; Katharina J Gerhold; Marzia Malcangio; Jürgen Sandkühler
Journal:  J Neurosci       Date:  2015-03-18       Impact factor: 6.167

Review 4.  Neuroplasticity of ascending and descending pathways after somatosensory system injury: reviewing knowledge to identify neuropathic pain therapeutic targets.

Authors:  P Boadas-Vaello; S Castany; J Homs; B Álvarez-Pérez; M Deulofeu; E Verdú
Journal:  Spinal Cord       Date:  2016-01-12       Impact factor: 2.772

Review 5.  Differences in Diurnal Variation of Immune Responses in Microglia and Macrophages: Review and Perspectives.

Authors:  Ricardo J Martínez-Tapia; Anahí Chavarría; Luz Navarro
Journal:  Cell Mol Neurobiol       Date:  2019-09-23       Impact factor: 5.046

6.  Cathepsin S causes inflammatory pain via biased agonism of PAR2 and TRPV4.

Authors:  Peishen Zhao; TinaMarie Lieu; Nicholas Barlow; Matthew Metcalf; Nicholas A Veldhuis; Dane D Jensen; Martina Kocan; Silvia Sostegni; Silke Haerteis; Vera Baraznenok; Ian Henderson; Erik Lindström; Raquel Guerrero-Alba; Eduardo E Valdez-Morales; Wolfgang Liedtke; Peter McIntyre; Stephen J Vanner; Christoph Korbmacher; Nigel W Bunnett
Journal:  J Biol Chem       Date:  2014-08-12       Impact factor: 5.157

7.  Inhibition of the activation and recruitment of microglia-like cells protects against neomycin-induced ototoxicity.

Authors:  Shan Sun; Huiqian Yu; Hui Yu; Mei Honglin; Wenli Ni; Yanping Zhang; Luo Guo; Yingzi He; Zhen Xue; Yusu Ni; Jin Li; Yi Feng; Yan Chen; Ruijin Shao; Renjie Chai; Huawei Li
Journal:  Mol Neurobiol       Date:  2014-05-01       Impact factor: 5.590

Review 8.  Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain.

Authors:  Zhi-Jun Zhang; Bao-Chun Jiang; Yong-Jing Gao
Journal:  Cell Mol Life Sci       Date:  2017-04-07       Impact factor: 9.261

Review 9.  Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity.

Authors:  Dimitris N Xanthos; Jürgen Sandkühler
Journal:  Nat Rev Neurosci       Date:  2013-11-27       Impact factor: 34.870

Review 10.  Emerging targets in neuroinflammation-driven chronic pain.

Authors:  Ru-Rong Ji; Zhen-Zhong Xu; Yong-Jing Gao
Journal:  Nat Rev Drug Discov       Date:  2014-06-20       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.